标题
Challenges in Chagas Disease Drug Development
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 12, Pages 2799
出版商
MDPI AG
发表日期
2020-06-19
DOI
10.3390/molecules25122799
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
- (2020) Gurdip Singh Mann et al. PLoS Neglected Tropical Diseases
- High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
- (2020) Jean A. Bernatchez et al. Microorganisms
- Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
- (2019) Julio Alonso-Padilla et al. Expert Review of Anti-Infective Therapy
- Identification of novel Trypanosoma cruzi proteasome inhibitors using a luminescence-based high-throughput screening assay.
- (2019) Filip Zmuda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
- (2019) Eric Pelfrene et al. PLoS Neglected Tropical Diseases
- Trypanosoma cruzi Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability Assessment
- (2019) Filip Zmuda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An evaluation of benznidazole as a Chagas disease therapeutic
- (2019) Ivo S. Caldas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Organometallic Gold(III) Complex [Au(Hdamp)(L14)]+ (L1 = SNS-Donating Thiosemicarbazone) as a Candidate to New Formulations against Chagas Disease
- (2019) Carla Duque Lopes et al. ACS Infectious Diseases
- Chagas Disease in the United States: a Public Health Approach
- (2019) Caryn Bern et al. CLINICAL MICROBIOLOGY REVIEWS
- Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
- (2019) Yves Jackson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice
- (2019) Andreas K Lindner et al. LANCET INFECTIOUS DISEASES
- Assessing the effectiveness of curative benznidazole treatment in preventing chronic cardiac pathology in experimental models of Chagas disease
- (2018) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum-based compound
- (2018) M. Florencia Mosquillo et al. Chemical Biology & Drug Design
- Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis
- (2018) Alan H. Fairlamb et al. CURRENT MEDICINAL CHEMISTRY
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- CYP51 as drug targets for fungi and protozoan parasites: past, present and future
- (2018) Galina I. Lepesheva et al. PARASITOLOGY
- Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
- (2018) Lorna M. MacLean et al. PLoS Neglected Tropical Diseases
- Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
- (2018) Fernando J Sánchez-Valdéz et al. eLife
- Effect of a new anti-T. cruzi metallic compound based on palladium
- (2018) M. Florencia Mosquillo et al. BIOMETALS
- The thiol-polyamine metabolism of Trypanosoma cruzi: molecular targets and drug repurposing strategies
- (2018) Alan Talevi et al. CURRENT MEDICINAL CHEMISTRY
- Imaging the development of chronic Chagas disease after oral transmission
- (2018) Michael D. Lewis et al. Scientific Reports
- Phenotypic screening approaches for Chagas disease drug discovery
- (2017) Eric Chatelain et al. Expert Opinion on Drug Discovery
- Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
- (2017) Stephen Brand et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease
- (2017) Mario J. Olivera et al. PLoS One
- Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole
- (2017) Mônica C. Campos et al. Scientific Reports
- Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation
- (2017) Paula Sartor et al. PLoS Neglected Tropical Diseases
- The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
- (2017) William K. Redekop et al. PLoS Neglected Tropical Diseases
- 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
- (2017) Claudia Magalhaes Calvet et al. PLoS Neglected Tropical Diseases
- Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani
- (2017) Leah S. Torrie et al. ACS Infectious Diseases
- Current drug therapy and pharmaceutical challenges for Chagas disease
- (2016) José Bermudez et al. ACTA TROPICA
- Host and parasite genetics shape a link betweenTrypanosoma cruziinfection dynamics and chronic cardiomyopathy
- (2016) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways
- (2016) Alice Machado-Silva et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Putting Infection Dynamics at the Heart of Chagas Disease
- (2016) Michael D. Lewis et al. TRENDS IN PARASITOLOGY
- Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
- (2016) Amanda Fortes Francisco et al. Scientific Reports
- Autoimmune Pathogenesis of Chagas Heart Disease
- (2015) Kevin M. Bonney et al. AMERICAN JOURNAL OF PATHOLOGY
- Impact of Benznidazole on Infection Course in Mice Experimentally Infected with Trypanosoma cruzi I, II, and IV
- (2015) Ana Paula Gruendling et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly SensitiveIn VivoImaging
- (2015) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease
- (2015) Shilpi Khare et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi
- (2015) M.H. Branquinha et al. CURRENT MEDICINAL CHEMISTRY
- Current and Future Chemotherapy for Chagas Disease
- (2015) Luís Gaspar et al. CURRENT MEDICINAL CHEMISTRY
- ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: Gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates
- (2015) Jaques Franco et al. INFECTION GENETICS AND EVOLUTION
- Dynamics of CYP51: implications for function and inhibitor design
- (2015) Xiaofeng Yu et al. JOURNAL OF MOLECULAR RECOGNITION
- Integrated control of Chagas disease for its elimination as public health problem - A Review
- (2015) Sergio Sosa-Estani et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2015) Carlos A. Morillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
- (2015) Tassiane Assíria Fontes Martins et al. PLoS One
- CD8+ T cells in Trypanosoma cruzi infection
- (2015) Rick L. Tarleton Seminars in Immunopathology
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- (2015) Jennifer Riley et al. PLoS Neglected Tropical Diseases
- Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: A Systematic Review and Meta-analysis
- (2015) Ana Requena-Méndez et al. PLoS Neglected Tropical Diseases
- Immunity and immune modulation inTrypanosoma cruziinfection
- (2015) Fabíola Cardillo et al. Pathogens and Disease
- Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
- (2014) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- Synthesis, Biological Evaluation, and Structure–Activity Relationships of Potent Noncovalent and Nonpeptidic Cruzain Inhibitors as Anti-Trypanosoma cruzi Agents
- (2014) Rafaela S. Ferreira et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chagas Disease Cardiomyopathy: Immunopathology and Genetics
- (2014) Edecio Cunha-Neto et al. MEDIATORS OF INFLAMMATION
- Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert
- (2014) Mônica C.O. Campos et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
- (2014) Carolina B. Moraes et al. Scientific Reports
- Benznidazole prevents endothelial damage in an experimental model of Chagas disease
- (2013) Alfredo Molina-Berríos et al. ACTA TROPICA
- Unveiling Benznidazole's mechanism of action through overexpression of DNA repair proteins inTrypanosoma cruzi
- (2013) Matheus Andrade Rajão et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Global economic burden of Chagas disease: a computational simulation model
- (2013) Bruce Y Lee et al. LANCET INFECTIOUS DISEASES
- Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
- (2012) Ana Maria Mejia et al. JOURNAL OF INFECTIOUS DISEASES
- Diagnosis and management of Chagas disease and cardiomyopathy
- (2012) Antonio L. Ribeiro et al. Nature Reviews Cardiology
- The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis
- (2012) S. Wyllie et al. Science Translational Medicine
- In vivosusceptibility to benznidazole ofTrypanosoma cruzistrains from the western Brazilian Amazon
- (2012) Ana P. M. Teston et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
- (2011) Belinda S. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
- (2011) Belinda S. Hall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
- (2011) Patricia S. Doyle et al. PLoS Pathogens
- Hydroxymethylnitrofurazone Is Active in a Murine Model of Chagas' Disease
- (2010) C. Davies et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chagas disease and stroke
- (2010) Francisco Javier Carod-Artal et al. LANCET NEUROLOGY
- The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 Å resolution
- (2010) Yihong Zhang et al. PROTEIN SCIENCE
- In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
- (2010) Yen Ting Chen et al. PLoS Neglected Tropical Diseases
- Red-emitting luciferases for bioluminescence reporter and imaging applications
- (2009) Bruce R. Branchini et al. ANALYTICAL BIOCHEMISTRY
- Trypanocidal drugs: mechanisms, resistance and new targets
- (2009) Shane R. Wilkinson et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Ergosterol biosynthesis and drug development for Chagas disease
- (2009) Julio A Urbina MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods
- (2008) Ricardo Luiz Santos Garcia et al. Acta Cirurgica Brasileira
- Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification
- (2008) Florencia Irigoín et al. FREE RADICAL BIOLOGY AND MEDICINE
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
- (2008) Shane R. Wilkinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search